908 Devices (MASS) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue reached $16.8 million, up 17% year-over-year, driven by handheld products, but below expectations due to delayed government spending and elongated sales cycles in life sciences.

• Revenue for the nine months ended September 30, 2024 was $40.8 million, up 14% year-over-year; net loss widened to $52.8 million, impacted by a $30.5 million goodwill impairment and higher operating expenses.

• Completed acquisition of RedWave Technology, expanding the forensics portfolio and contributing $6.3 million in revenue; integration is ongoing and expected to accelerate growth and profitability.

• Structural changes include manufacturing consolidation, 11% workforce reduction, and sales integration to drive efficiency and annualized savings of over $7.5 million.

• Strong momentum with product launches, strategic acquisitions, and industry awards in 2023 and 2024.

Financial highlights

• Handheld revenue was $14 million in Q3 2024, up 19% year-over-year; desktop revenue was $2.8 million, up 8%.

• Total revenue for the first nine months of 2024 was $40.8 million, up 14% year-over-year; recurring revenue grew to 39% of product and service revenue.

• Gross profit was $8.3 million (50% margin) in Q3 2024; adjusted gross profit was $9.3 million (55% margin).

• Net loss was $29.3 million in Q3 2024, impacted by a $30.5 million non-cash goodwill impairment; net loss per share was $(0.84).

• Cash, cash equivalents, and marketable securities totaled $71.7 million at quarter-end, with no debt.

Outlook and guidance

• 2024 revenue guidance lowered to $56–$58 million (11–15% growth), including ~$10 million from RedWave; core business revenue expected to decline 4–8% year-over-year.

• Adjusted gross margin expected in the mid-50% range for 2024, with further expansion in 2025.

• Management expects continued operating losses as investments in R&D, sales, and manufacturing scale; cash on hand expected to fund operations for at least 12 months.

• Restructuring and manufacturing consolidation are aimed at reducing annual cash burn and improving efficiency in 2025.

• 2025 anticipated as a transformational year with margin expansion and cost optimization.